ARQT FY 2024 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$197M+229.7% YoY

Gross Profit

$177M90.3% margin

Operating Income

-$128M-65.3% margin

Net Income

-$140M-71.3% margin

EPS (Diluted)

$-1.16

Cash Flow

Operating Cash Flow

-$112M

Free Cash Flow

-$112M

Stock-Based Comp.

$42M

Balance Sheet

Total Assets

$349M

Total Liabilities

$191M

Stockholders' Equity

$158M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$197M	$60M	+229.7%
Gross Profit	$177M	$55M	+224.8%
Operating Income	-$128M	-$241M	+46.7%
Net Income	-$140M	-$262M	+46.6%